Research and development to support the investigation of novel antimalarial drug targets through affinity-based pulldowns.
Active Definitive Contract Awarded Last action
- Contract number
- HT942525CE040
- Awardee
-
Portland State University UEI H4CAHK2RD945
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $46,491
Award facts
- Contract value 77% obligated
- $60,459.98 Current and potential, with all options
- Completion date 55% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Portland, OR 97207, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Original award | $46,491 |
About this award
The Defense Health Agency awarded a $60,459.98 definitive contract to Portland State University on September 30, 2025, for research and development supporting the investigation of novel antimalarial drug targets through affinity-based pulldowns. No set-aside was used. The contract is priced cost no fee and reaches ultimate completion on September 29, 2027.
Place of performance is Portland, Oregon 97207.
Quick answers
Who was awarded contract HT942525CE040?
HT942525CE040 was awarded to Portland State University by Defense Health Agency (Department of Defense) on September 30, 2025.
How much is contract HT942525CE040 worth?
The government has obligated $46,491 on HT942525CE040. Its current value, with exercised options, is $60,460.
Was contract HT942525CE040 competed?
The extent of competition for HT942525CE040 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award